2025 HCPCS Code C7562
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention
TAGS: imaging values atherosclerotic angiogram intervention possible catheterization fractional review functional catheter supervision performed heart derived placement mapping coronary intraprocedural reserve right interpretation| Short Description | R&l hrt angio w/ffr & 3d map |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2025 |
| HCPCS Action Effective Date | January 01, 2025 |
| HCPCS Pricing Indicator Code | 99 - Value not established |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9478 - Injection, sebelipase alfa
- C9479 - Instill, ciprofloxacin otic
- C9480 - Injection, trabectedin
- C9481 - Injection, reslizumab
- C9482 - Sotalol hydrochloride iv
- C9483 - Injection, atezolizumab
- C9484 - Injection, eteplirsen
- C9485 - Injection, olaratumab
- C9486 - Inj, granisetron ext
- C9487 - Ustekinumab iv inj, 1 mg
- C9488 - Conivaptan hcl
- C9489 - Injection, nusinersen
- C9490 - Injection, bezlotoxumab
- C9491 - Injection, avelumab
- C9492 - Injection, durvalumab
- C9493 - Injection, edaravone
- C9494 - Injection, ocrelizumab
- C9497 - Loxapine, inhalation powder
- C9507 - Covid-19 convalescent plasma
- C9600 - Perc drug-el cor stent sing
